文献速递心脑血管急症

冠状动脉旁路移植术中内镜与开放式静脉桥血管获取的随机试验

Randomized Trial of Endoscopic or Open Vein-Graft Harvesting for Coronary-Artery Bypass.
PubMed 文献 · N Engl J Med · 2018-11-11
一句话结论CABG患者中,内镜与开放式大隐静脉获取的主要不良心脏事件风险无显著差异(15.5% vs 13.9%,HR 1.12,95%CI 0.83–1.51,P=0.47)。

该多中心随机试验在16个退伍军人事务部心脏外科中心纳入1150例接受CABG的患者,随机分配至开放式或内镜静脉桥血管获取。中位随访2.78年,主要复合终点(全因死亡、非致死性心肌梗死、再次血运重建)在开放组89例(15.5%)、内镜组80例(13.9%),HR 1.12(95%CI 0.83–1.51,P=0.47),无显著差异。全因死亡、心肌梗死、再次血运重建及腿部伤口感染各次要终点亦均无显著差异。结论认为两种获取方式在主要不良心脏事件风险上无显著差异。

要点

  • 中位随访2.78年,主要复合终点开放组15.5% vs 内镜组13.9%,HR 1.12(95%CI 0.83–1.51,P=0.47),无显著差异。
  • 全因死亡开放组8.0% vs 内镜组6.4%,HR 1.25(95%CI 0.81–1.92),无显著差异。
  • 心肌梗死开放组5.9% vs 内镜组4.7%,HR 1.27(95%CI 0.77–2.11),无显著差异。
  • 再次血运重建开放组6.1% vs 内镜组5.4%,HR 1.14(95%CI 0.70–1.85),无显著差异。
  • 腿部伤口感染开放组3.1% vs 内镜组1.4%,RR 2.26(95%CI 0.99–5.15),无显著差异。

适用人群与场景

  • 在16个退伍军人事务部心脏外科中心接受冠状动脉旁路移植术(CABG)的患者。

研究设计与关键结果

  • 研究类型:随机对照试验,16个退伍军人事务部心脏外科中心,1150例接受CABG的患者随机分配至开放式或内镜静脉桥血管获取。
  • 主要终点为主要不良心脏事件复合终点(全因死亡、非致死性心肌梗死、再次血运重建),中位随访2.78年,开放组89例(15.5%)vs 内镜组80例(13.9%),HR 1.12(95%CI 0.83–1.51,P=0.47)。
  • 全因死亡:开放组46例(8.0%)vs 内镜组37例(6.4%),HR 1.25(95%CI 0.81–1.92)。
  • 心肌梗死:开放组34例(5.9%)vs 内镜组27例(4.7%),HR 1.27(95%CI 0.77–2.11)。
  • 再次血运重建:开放组35例(6.1%)vs 内镜组31例(5.4%),HR 1.14(95%CI 0.70–1.85)。
  • 腿部伤口感染:开放组18例(3.1%)vs 内镜组8例(1.4%),RR 2.26(95%CI 0.99–5.15)。

证据类型、等级与局限

  • 证据类型:随机对照试验。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者结论:在接受CABG的患者中,未发现开放式与内镜静脉桥血管获取在主要不良心脏事件风险上有显著差异。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: The saphenous-vein graft is the most common conduit for coronary-artery bypass grafting (CABG). The influence of the vein-graft harvesting technique on long-term clinical outcomes has not been well characterized.

METHODS: We randomly assigned patients undergoing CABG at 16 Veterans Affairs cardiac surgery centers to either open or endoscopic vein-graft harvesting. The primary outcome was a composite of major adverse cardiac events, including death from any cause, nonfatal myocardial infarction, and repeat revascularization. Leg-wound complications were also evaluated.

RESULTS: A total of 1150 patients underwent randomization. Over a median follow-up of 2.78 years, the primary outcome occurred in 89 patients (15.5%) in the open-harvest group and 80 patients (13.9%) in the endoscopic-harvest group (hazard ratio, 1.12; 95% confidence interval [CI], 0.83 to 1.51; P=0.47). A total of 46 patients (8.0%) in the open-harvest group and 37 patients (6.4%) in the endoscopic-harvest group died (hazard ratio, 1.25; 95% CI, 0.81 to 1.92); myocardial infarctions occurred in 34 patients (5.9%) in the open-harvest group and 27 patients (4.7%) in the endoscopic-harvest group (hazard ratio, 1.27; 95% CI, 0.77 to 2.11), and revascularization occurred in 35 patients (6.1%) in the open-harvest group and 31 patients (5.4%) in the endoscopic-harvest group (hazard ratio, 1.14; 95% CI, 0.70 to 1.85). Leg-wound infections occurred in 18 patients (3.1%) in the open-harvest group and in 8 patients (1.4%) in the endoscopic-harvest group (relative risk, 2.26; 95% CI, 0.99 to 5.15).

CONCLUSIONS: Among patients undergoing CABG, we did not find a significant difference between open vein-graft harvesting and endoscopic vein-graft harvesting in the risk of major adverse cardiac events. (Funded by the Cooperative Studies Program, Office of Research and Development, Department of Veterans Affairs; REGROUP ClinicalTrials.gov number, NCT01850082 .).

来源:N Engl J Med,查看原文。版权归原作者所有。

参考来源

  1. Zenati MA, Bhatt DL, Bakaeen FG, et al. Randomized Trial of Endoscopic or Open Vein-Graft Harvesting for Coronary-Artery Bypass. N Engl J Med. 2018. PMID: 30417737. doi:10.1056/NEJMoa1812390

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。